Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

N E Rhaleb

Showing results (31-40 of 54) with videos related to

Pageof 6
Sort By:
Hypertension (Dallas, Tex. : 1979)|March 7, 2001
Antifibrotic effects of N-acetyl-seryl-aspartyl-Lysyl-proline on the heart and kidney in aldosterone-salt hypertensive ratsH Peng, O A Carretero, L Raij, et al.
Annals of the New York Academy of Sciences|January 1, 1988
Receptors for neurokinins, tachykinins, and bombesin: a pharmacological studyD Regoli, S Dion, N E Rhaleb, et al.
Pharmacological Research|January 1, 1990
Neurokinin A. A pharmacological studyD Regoli, N E Rhaleb, S Dion, et al.
Agents and Actions|September 1, 1991
New highly potent bradykinin B2 receptor antagonistsD Regoli, N E Rhaleb, C Tousignant, et al.
European Journal of Pharmacology|March 29, 1989
Receptors for kinins in isolated arterial vessels of dogsN E Rhaleb, S Dion, J Barabé, et al.
Hypertension (Dallas, Tex. : 1979)|January 1, 1991
Structure-activity studies of bradykinin and related peptides. B2-receptor antagonistsN E Rhaleb, S Télémaque, N Rouissi, et al.
European Journal of Pharmacology|January 14, 1992
Pharmacological characterization of a new highly potent B2 receptor antagonist (HOE 140: D-Arg-[Hyp3,Thi5,D-Tic7,Qic8]bradykinin)N E Rhaleb, N Rouissi, D Jukic, et al.
European Journal of Pharmacology|July 7, 1988
Bradykinin antagonism: differentiation between peptide antagonists and antiinflammatory agentsN E Rhaleb, S Dion, P D'Orléans-Juste, et al.
Hypertension (Dallas, Tex. : 1979)|March 13, 2001
Effect of N-acetyl-seryl-aspartyl-lysyl-proline on DNA and collagen synthesis in rat cardiac fibroblastsN E Rhaleb, H Peng, P Harding, et al.
Neuropeptides|July 1, 1987
Selective agonists for substance P and neurokinin receptorsG Drapeau, P D'Orléans-Juste, S Dion, et al.
Pageof 6

Showing results (31-40 of 54) with videos related to

Sort By:
Pageof 6
Hypertension (Dallas, Tex. : 1979)|March 7, 2001
Antifibrotic effects of N-acetyl-seryl-aspartyl-Lysyl-proline on the heart and kidney in aldosterone-salt hypertensive ratsH Peng, O A Carretero, L Raij, et al.
Annals of the New York Academy of Sciences|January 1, 1988
Receptors for neurokinins, tachykinins, and bombesin: a pharmacological studyD Regoli, S Dion, N E Rhaleb, et al.
Pharmacological Research|January 1, 1990
Neurokinin A. A pharmacological studyD Regoli, N E Rhaleb, S Dion, et al.
Agents and Actions|September 1, 1991
New highly potent bradykinin B2 receptor antagonistsD Regoli, N E Rhaleb, C Tousignant, et al.
European Journal of Pharmacology|March 29, 1989
Receptors for kinins in isolated arterial vessels of dogsN E Rhaleb, S Dion, J Barabé, et al.
Hypertension (Dallas, Tex. : 1979)|January 1, 1991
Structure-activity studies of bradykinin and related peptides. B2-receptor antagonistsN E Rhaleb, S Télémaque, N Rouissi, et al.
European Journal of Pharmacology|January 14, 1992
Pharmacological characterization of a new highly potent B2 receptor antagonist (HOE 140: D-Arg-[Hyp3,Thi5,D-Tic7,Qic8]bradykinin)N E Rhaleb, N Rouissi, D Jukic, et al.
European Journal of Pharmacology|July 7, 1988
Bradykinin antagonism: differentiation between peptide antagonists and antiinflammatory agentsN E Rhaleb, S Dion, P D'Orléans-Juste, et al.
Hypertension (Dallas, Tex. : 1979)|March 13, 2001
Effect of N-acetyl-seryl-aspartyl-lysyl-proline on DNA and collagen synthesis in rat cardiac fibroblastsN E Rhaleb, H Peng, P Harding, et al.
Neuropeptides|July 1, 1987
Selective agonists for substance P and neurokinin receptorsG Drapeau, P D'Orléans-Juste, S Dion, et al.
Pageof 6